| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Department of Histology and Medical Embryology Institute (S.M.), University of Rome La Sapienza, Rome 00161, Italy; Receptor Biology Section, Laboratory of Reproductive and Developmental Toxicology (S.M., T.F.W., K.S.K.), and Hormone Action Group, Laboratory of Signal Transduction (S.F., H.R., W.C.W.), National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709; the Department of Psychiatry and Behavioral Sciences, Duke University Medical Center (W.C.W.), Durham, North Carolina 27710; and the Department of Experimental Medicine, University of LAquila (A.T.), Rome, Italy 67100
Address all correspondence and requests for reprints to: Silvia Migliaccio, M.D., Ph.D., Histology and Medical Embryology Department, University of Rome La Sapienza, Via Antonio Scarpa 14, Rome 00161, Italy. E-mail: ateti{at}axrma.uniroma1.it
We have recently shown that protein kinase C (PKC) modifies estrogen
receptor (ER) binding and modulates the responsiveness to estrogens in
a clonal osteoblast-like cell line stably transfected with the ER. The
purpose of the present study was to determine whether the interaction
observed between the ER and PKC signaling in these cells occurs in
additional estrogen target organs, such as the uterus. When uteri were
incubated for 2 h with increasing concentrations of a kinase
inhibitor (H7), ER binding was enhanced in a dose-dependent manner.
Stimulation of PKC with phorbol ester reduced PKC activity levels, but
increased ER binding. Interestingly, the changes in binding appeared to
be due primarily to alterations in cytosolic ER levels, as binding in
the nuclear fraction was minimally enhanced. When levels of ER
messenger RNA were evaluated by Northern blot analysis, no differences
were observed among the H7- or
12-O-tetradecanoylphorbol-13-acetate (TPA)-treated and
untreated groups. Western blot analysis, however, demonstrated that
levels of ER cytosolic protein in the H7-, TPA-, and
staurosporine-treated groups were increased relative to those in the
untreated controls. When uteri were incubated with diethylstilbestrol
in the presence of either H7 or TPA, no change in cytosolic ER levels
was found, suggesting that only unoccupied ERs are responsive to
modulation by PKC. Western blotting of the various PKC isoforms
indicated that although PKC
, -ßI, -ßII,
-
, and -
are expressed in the uterus, only PKC
and
-ßI are translocated from the soluble to the particulate
fraction and then degraded after phorbol ester stimulation. Hence, one
or both of these latter PKC isoforms may regulate cytosolic ER levels.
Collectively, these data indicate that PKC may play an important role
in the modulation of uterine ER levels and that PKC may exert its
effect on the ER at some posttranscriptional or posttranslational step.
Finally, our results show that an ER-PKC interaction occurs in a whole
organ such as the uterus and that this interaction may be important in
the regulation of the ER activity in a variety of estrogen-responsive
tissues.
This article has been cited by other articles:
![]() |
B. Chen, D. Zhang, and J. W. Pollard Progesterone Regulation of the Mammalian Ortholog of Methylcitrate Dehydratase (Immune Response Gene 1) in the Uterine Epithelium during Implantation through the Protein Kinase C Pathway Mol. Endocrinol., November 1, 2003; 17(11): 2340 - 2354. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |